Synergy Pharmaceuticals Inc. Unit

(SGYPU) Trade

By |

Profile

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Contact Information

Website: www.synergypharma.com
Email: SynergyIR@edelman.com
Main Phone: +1 212 297-0020
Address: 420 Lexington Avenue
Address 2: Suite 2012
State: NY
City / Town: New York
Country: USA
Postal Code: 10170

Issuer Information

Exchange: NSC
CEO: Troy Hamilton
Employees: 313
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 12.16 52 Wk Low 6.36
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,818,182.00 EPS (TTM) N/A PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
John P. Brancaccio 1,000
Gary S. Jacob 1,000
Kunwar Shailubhai 1,000
Bernard F. Denoyer 1,000
Gabriele M. Cerrone 1,000
Bernard F. Denoyer 1,000
Gabriele M. Cerrone 1,000
Last 10 Sell Shares
N/A 0